|
Index of reports
> Cases resulting in life threatening events (42)
Below is the selection of adverse event reports related to Voltaren (Diclofenac) that includes cases resulting in life threatening events.
Reports 1 - 25 of 42 Next >>
Adverse event in female receiving Voltaren (Diclofenac)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-30
Patient: female
Adverse reactions / side effects: Gastrointestinal Infection, Toxic Epidermal Necrolysis
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Apresoline
Administration route: Oral
Indication: Hypertension
Baktar
Administration route: Oral
Indication: Interstitial Lung Disease
Cravit
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Dormicum
Indication: Sedation
Lansoprazole
Indication: Gastric Ulcer
Lansoprazole
Administration route: Oral
Norvasc
Administration route: Oral
Indication: Hypertension
Olmetec
Administration route: Oral
Indication: Hypertension
Omegacin
Indication: Interstitial Lung Disease
Pentazocine Lactate
Indication: Sedation
Prodif
Indication: Interstitial Lung Disease
Voltaren
Indication: Hyperthermia
Other drugs received by patient: Rheumatrex; Rimatil; Solu-Medrol; Elaspol; Predonine; Predonine
Adverse event in 59 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-10-25
Patient: 59 year old female
Adverse reactions / side effects: Toxic Epidermal Necrolysis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Apresoline
Dosage: 100 mg (50 mg, 2 in 1 d), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-07-23
End date: 2007-08-03
Baktar (Sulfamethoxazole, Trimethoprim) (Sulfamethoxazole, Trimethopri
Dosage: 2 gm (1 gm, 2 in 1 d), per oral
Administration route: Oral
Indication: Interstitial Lung Disease
Start date: 2007-07-25
End date: 2007-08-01
Cravit (Levofloxacin) (Tablet) (Levofloxacin)
Dosage: 400 mg (200 mg, 1 in 1 d), per oral
Administration route: Oral
Indication: Toxic Epidermal Necrolysis
Start date: 2007-08-08
End date: 2007-08-12
Dormicum (Midazolam Hydrohloride) (Injection) (Midazolam Hydrochloride
Dosage: continuous intravenous (not otherwise specified)
Indication: Sedation
Start date: 2007-07-23
End date: 2007-07-28
Norvasc
Dosage: 5 mg ( 5 mg, 1 in 1 d) per oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-08-08
End date: 2007-08-21
Olmesartan Medoxomil
Dosage: 20 mg (20 mg, 1 in 1 d), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-08-08
End date: 2007-08-21
Omegacin (Biapenem) (Injection) (Biapenem)
Dosage: 600 mg (300 mg, 2 in 1 d), intravenous drip
Indication: Interstitial Lung Disease
Start date: 2007-07-23
End date: 2007-08-04
Prodif (Injection)
Dosage: 800 mg, 400 mg (2 in 1 d), intavenous (not otherwise specified)
Indication: Interstitial Lung Disease
Start date: 2007-07-23
End date: 2007-08-04
Sosegon (Pentazocine) (Injection) (Pentazocine)
Dosage: continuous intravenous (not otherwise specified)
Indication: Sedation
Start date: 2007-07-23
End date: 2007-07-28
Takepron (Lansoprazole) (Injection) (Lansoprazole)
Dosage: 60 mg (30 mg, 2 in 1 d), intravenous drip; 30 mg (30 mg, 1 in 1 d), per oral
Administration route: Oral
Indication: Gastric Ulcer
Start date: 2007-07-23
End date: 2007-08-03
Takepron (Lansoprazole) (Injection) (Lansoprazole)
Dosage: 60 mg (30 mg, 2 in 1 d), intravenous drip; 30 mg (30 mg, 1 in 1 d), per oral
Administration route: Oral
Indication: Gastric Ulcer
Start date: 2007-08-04
End date: 2007-08-21
Voltaren
Dosage: continuous intravenous ( otherwise not specified)
Indication: Hyperthermia
Start date: 2007-07-23
End date: 2007-08-05
Adverse event in 56 year old female receiving Voltaren (Diclofenac)
Reported by a physician from Norway on 2007-10-24
Patient: 56 year old female
Adverse reactions / side effects: Dyspnoea, Hyponatraemia, Obstructive Airways Disorder, Generalised Oedema
Adverse event resulted in: life threatening event
Suspect drug(s):
Brexidol
Administration route: Oral
Indication: Arthralgia
Cozaar
Dosage: 1 df, qd
Administration route: Oral
Indication: Hypertension
Diural
Dosage: 40 mg, qd
Administration route: Oral
Indication: Oedema
Start date: 2007-08-28
Ibux
Indication: Arthralgia
Start date: 2007-08-01
Naproxen
Administration route: Oral
Indication: Arthralgia
Voltaren
Dosage: 50 mg, tid
Administration route: Oral
Indication: Arthralgia
Start date: 2007-08-01
Other drugs received by patient: Pinex Forte; Doxylin; Vival; Noni Juice; Pinex; Fenazon-Koffein
Adverse event in female receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-10-24
Patient: female
Adverse reactions / side effects: Toxic Epidermal Necrolysis, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Apresoline
Administration route: Oral
Indication: Hypertension
Start date: 2007-07-30
End date: 2007-08-07
Baktar
Administration route: Oral
Start date: 2007-07-25
End date: 2007-08-01
Biapenem
Indication: Interstitial Lung Disease
Start date: 2007-07-23
End date: 2007-08-08
Dormicum FOR Injection
Indication: Sedation
Start date: 2007-07-23
End date: 2007-07-28
Elaspol
Lansoprazole
Indication: Gastric Ulcer
Start date: 2007-07-23
End date: 2007-08-03
Lansoprazole
Dosage: daily dose:30mg
Administration route: Oral
Start date: 2007-08-04
End date: 2007-08-21
Levofloxacin
Administration route: Oral
Start date: 2007-08-08
End date: 2007-08-12
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2007-08-08
End date: 2007-08-27
Olmetec
Administration route: Oral
Indication: Hypertension
Start date: 2007-08-08
End date: 2007-08-21
Pentazocine Lactate
Start date: 2007-07-23
End date: 2007-07-28
Prodif
Indication: Fungal Infection
Start date: 2007-07-23
End date: 2007-08-04
Voltaren
Dosage: daily dose:25mg-freq:frequency: prn
Indication: Pyrexia
Start date: 2007-07-23
End date: 2007-08-05
Other drugs received by patient: Flumetholon; Prednisolone
Adverse event in female receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-10-17
Patient: female
Adverse reactions / side effects: Toxic Epidermal Necrolysis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Apresoline
Administration route: Oral
Indication: Hypertension
Start date: 2007-07-30
End date: 2007-08-07
Baktar
Administration route: Oral
Start date: 2007-07-25
End date: 2007-08-01
Biapenem
Indication: Interstitial Lung Disease
Start date: 2007-07-23
End date: 2007-08-08
Dormicum FOR Injection
Indication: Sedation
Start date: 2007-07-23
End date: 2007-07-28
Elaspol
Lansoprazole
Indication: Gastric Ulcer
Start date: 2007-07-23
End date: 2007-08-03
Lansoprazole
Dosage: daily dose:30mg
Administration route: Oral
Start date: 2007-08-04
End date: 2007-08-21
Levofloxacin
Administration route: Oral
Start date: 2007-08-08
End date: 2007-08-12
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2007-08-08
End date: 2007-08-27
Olmetec
Administration route: Oral
Indication: Hypertension
Start date: 2007-08-08
End date: 2007-08-21
Prodif
Indication: Fungal Infection
Start date: 2007-07-23
End date: 2007-08-04
Voltaren
Dosage: daily dose:25mg-freq:frequency: prn
Indication: Pyrexia
Start date: 2007-07-23
End date: 2007-08-05
Other drugs received by patient: Flumetholon; Prednisolone; Pentazocine Lactate
Adverse event in 59 year old female receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-10-16
Patient: 59 year old female
Adverse reactions / side effects: Skin Exfoliation, Necrosis, Blood Albumin Decreased, Haematocrit Decreased, RED Blood Cell Count Decreased, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, Blister, Lymphocyte Count Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Toxic Epidermal Necrolysis, Blood Cholinesterase Decreased, Protein Total Decreased, Haemoglobin Decreased, Rash Erythematous, Skin Erosion
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Apresolin
Dosage: 50 mg, bid
Administration route: Oral
Indication: Hypertension
Start date: 2007-07-30
End date: 2007-08-08
Baktar
Dosage: 2 g/day
Administration route: Oral
Indication: Interstitial Lung Disease
Start date: 2007-07-24
End date: 2007-08-01
Dormicum
Dosage: 10 ug/day
Indication: Sedation
Start date: 2007-07-23
End date: 2007-07-28
Lansoprazole
Dosage: 60 mg/day
Indication: Gastric Ulcer
Start date: 2007-07-23
End date: 2007-08-03
Lansoprazole
Dosage: 30 mg/day
Administration route: Oral
Start date: 2007-08-04
End date: 2007-08-21
Levofloxacin
Dosage: 400 mg/day
Administration route: Oral
Indication: Infection
Start date: 2007-08-08
End date: 2007-08-12
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2007-08-08
End date: 2007-08-21
Olmetec
Dosage: unk, unk
Administration route: Oral
Start date: 2007-08-08
End date: 2007-08-21
Omegacin
Dosage: 600 mg/day
Indication: Interstitial Lung Disease
Start date: 2007-07-23
End date: 2007-08-04
Pentazocine Lactate
Dosage: 30 ug/day
Indication: Sedation
Start date: 2007-07-23
End date: 2007-07-28
Prodif
Dosage: 800 mg/day
Start date: 2007-07-23
End date: 2007-08-04
Prodif
Dosage: 400 mg/day
Start date: 2007-07-23
End date: 2007-08-04
Voltaren
Dosage: 25 mg/day
Indication: Antipyresis
Start date: 2007-07-23
End date: 2007-08-05
Other drugs received by patient: Polymyxin B; Elaspol
Adverse event in 75 year old female receiving Voltaren (Diclofenac)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-16
Patient: 75 year old female, weighing 49.0 kg (107.8 pounds)
Adverse reactions / side effects: Hypoventilation, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Anaphylactic Shock, Hypoaesthesia, Hypoxic Encephalopathy, Heart Rate Decreased, Gamma-Glutamyltransferase Increased, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Nuclear Magnetic Resonance Imaging Abnormal, Blood Sodium Increased, Blood Pressure Immeasurable, Altered State of Consciousness
Adverse event resulted in: life threatening event
Suspect drug(s):
Voltaren (Diclofenac)
Adverse event in 60 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-10-02
Patient: 60 year old male, weighing 62.0 kg (136.4 pounds)
Adverse reactions / side effects: Intermittent Positive Pressure Breathing, Pco2 Decreased, Dyspnoea, Stridor, Hypercapnia, Blood PH Decreased, Status Asthmaticus, Japan Coma Scale Abnormal, Altered State of Consciousness, Cough
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren
Dosage: 50 mg/day
Indication: Neck Pain
Start date: 2007-02-14
Voltaren
Dosage: 50 mg/day
Start date: 2007-02-14
Adverse event in 60 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-10-02
Patient: 60 year old male, weighing 62.0 kg (136.4 pounds)
Adverse reactions / side effects: Intermittent Positive Pressure Breathing, Pco2 Decreased, Dyspnoea, Stridor, Hypercapnia, Blood PH Decreased, Status Asthmaticus, Japan Coma Scale Abnormal, Altered State of Consciousness, Cough
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren
Dosage: 50 mg/day
Indication: Neck Pain
Start date: 2007-02-14
Voltaren
Dosage: 50 mg/day
Start date: 2007-02-14
Adverse event in 57 year old male receiving Voltaren (Diclofenac)
Reported by a physician from Germany on 2007-07-30
Patient: 57 year old male, weighing 76.0 kg (167.2 pounds)
Adverse reactions / side effects: Skin Discolouration, Purulence, Rash, Erythema, Secretion Discharge
Adverse event resulted in: life threatening event
Suspect drug(s):
Voltaren (Diclofenac)
Adverse event in 61 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-07-16
Patient: 61 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Drug Eruption, Thoracic Cavity Drainage, Disseminated Intravascular Coagulation, Pyrexia, Erythema, Laboratory Test Abnormal, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Pleural Effusion, Blood Creatinine Increased, Lymphocyte Count Decreased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Blood Urea Increased, Dyspnoea, Neutrophil Count Increased, Monocyte Count Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Urine Output Decreased, Lymphocyte Stimulation Test Positive, Rash Macular, Haemoglobin Decreased, Renal Failure, Aspartate Aminotransferase Increased, Oliguria, Platelet Count Decreased, Lung Infiltration
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Dacarbazine
Dosage: 180 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Feron
Dosage: 3000000 iu/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Loxonin
Dosage: 60 mg, tid
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-10
End date: 2005-11-13
Nidran
Dosage: 100 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Oncovin
Dosage: 1 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Voltaren
Dosage: 37.5 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-09
End date: 2005-11-10
Other drugs received by patient: Norvasc; Towamin; Lipitor; Voglibose
Adverse event in 44 year old male receiving Voltaren (Diclofenac)
Reported by a health professional (non-physician/pharmacist) from Denmark on 2007-07-11
Patient: 44 year old male
Adverse reactions / side effects: Intracardiac Thrombus
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Ibuprofen
Adverse event in 69 year old male receiving Voltaren (Diclofenac)
Reported by a consumer/non-health professional from Italy on 2007-07-05
Patient: 69 year old male
Adverse reactions / side effects: Defaecation Urgency, Dyspnoea, Swollen Tongue, Laryngeal Oedema, Feeling Abnormal, Hyperhidrosis, Paraesthesia
Adverse event resulted in: life threatening event
Suspect drug(s):
Calcium Chloride
Voltaren
Indication: Musculoskeletal Chest Pain
Start date: 2007-04-09
Voltaren
Dosage: 50 mg, unk
Start date: 2007-06-29
Adverse event in 44 year old male receiving Voltaren (Diclofenac)
Reported by a health professional (non-physician/pharmacist) from Denmark on 2007-07-02
Patient: 44 year old male
Adverse reactions / side effects: Intracardiac Thrombus
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Ibuprofen
Adverse event in 2 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-07-02
Patient: 2 year old male, weighing 13.0 kg (28.6 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Myoglobinuria, Blood Creatine Phosphokinase Increased, Hepatic Necrosis, Rhabdomyolysis, Hepatic Failure, Resuscitation, Hypoxia, Myoglobin Blood Increased, Blood Creatinine Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, Haemodialysis, Hepatic Steatosis, Renal Failure, Aspartate Aminotransferase Increased, Depressed Level of Consciousness, Prothrombin Time Shortened, Retroperitoneal Neoplasm, Bradycardia, Obstructive Airways Disorder, Venous Occlusion
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Fentanyl
Nitrous Oxide W / Oxygen
Vecuronium Bromide
Voltaren
Adverse event in 61 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-29
Patient: 61 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Thoracic Cavity Drainage, Disseminated Intravascular Coagulation, Pyrexia, Erythema, Laboratory Test Abnormal, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Pleural Effusion, Blood Creatinine Increased, Lymphocyte Count Decreased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Monocyte Count Decreased, Neutrophil Count Increased, Blood Urea Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Urine Output Decreased, Lymphocyte Stimulation Test Positive, Rash Macular, Haemoglobin Decreased, Renal Failure, Aspartate Aminotransferase Increased, Oliguria, Platelet Count Decreased, Lung Infiltration
Adverse event resulted in: life threatening event
Suspect drug(s):
Dacarbazine
Dosage: 180 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Feron
Dosage: 3000000 iu/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Loxonin
Dosage: 60 mg, tid
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-10
End date: 2005-11-13
Nidran
Dosage: 100 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Oncovin
Dosage: 1 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Voltaren
Dosage: 37.5 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-09
End date: 2005-11-10
Other drugs received by patient: Norvasc; Towamin; Lipitor; Voglibose
Adverse event in 83 year old female receiving Voltaren (Diclofenac)
Reported by a health professional (non-physician/pharmacist) from Austria on 2007-06-25
Patient: 83 year old female
Adverse reactions / side effects: Vomiting, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion, Cognitive Disorder, Blood Sodium Decreased, Delirium
Adverse event resulted in: life threatening event
Suspect drug(s):
Acecomb
Acemin
Citalopram Hydrobromide
Furospirobene
Tegretol
Voltaren
Adverse event in 61 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-19
Patient: 61 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Thoracic Cavity Drainage, Disseminated Intravascular Coagulation, Pyrexia, Laboratory Test Abnormal, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Pleural Effusion, Blood Creatinine Increased, Oxygen Saturation Decreased, Lymphocyte Count Decreased, White Blood Cell Count Increased, Neutrophil Count Increased, Blood Urea Increased, Dyspnoea, Monocyte Count Decreased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Urine Output Decreased, Lymphocyte Stimulation Test Positive, Rash Macular, Haemoglobin Decreased, Renal Failure, Aspartate Aminotransferase Increased, Oliguria, Platelet Count Decreased, Lung Infiltration
Adverse event resulted in: life threatening event
Suspect drug(s):
Dacarbazine
Dosage: 180 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Feron
Dosage: 3000000 iu/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Loxonin
Dosage: 60 mg, tid
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-10
End date: 2005-11-13
Nidran
Dosage: 100 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Oncovin
Dosage: 1 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Voltaren
Dosage: 37.5 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-09
End date: 2005-11-10
Other drugs received by patient: Norvasc; Towamin; Lipitor; Voglibose
Adverse event in female receiving Voltaren (Diclofenac)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-06-15
Patient: female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Colitis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Enbrel
Dosage: 50 mg per week
Indication: Polyarthritis
Start date: 2005-09-01
End date: 2007-04-01
Syntestan
Dosage: 5-10 mg per day
Administration route: Oral
Indication: Polyarthritis
Voltaren
Dosage: 2 capsules per day
Administration route: Oral
Indication: Polyarthritis
Adverse event in 26 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Australia on 2007-06-14
Patient: 26 year old female
Adverse reactions / side effects: LIP Swelling, Hypotension, Circulatory Collapse, Paraesthesia, Generalised Oedema
Adverse event resulted in: life threatening event
Suspect drug(s):
Voltaren (Diclofenac)
Adverse event in 29 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Australia on 2007-06-14
Patient: 29 year old female
Adverse reactions / side effects: Eyelid Oedema, Dyspnoea, Tachycardia, Respiratory Distress
Adverse event resulted in: life threatening event
Suspect drug(s):
Voltaren (Diclofenac)
Adverse event in receiving Voltaren (Diclofenac)
Reported by a pharmacist from Japan on 2007-06-11
Patient:
Adverse reactions / side effects: Cardio-Respiratory Arrest, Hepatitis Fulminant, Hepatic Enzyme Increased
Adverse event resulted in: life threatening event
Suspect drug(s):
Voltaren (Diclofenac)
Adverse event in 83 year old female receiving Voltaren (Diclofenac)
Reported by a health professional (non-physician/pharmacist) from Austria on 2007-06-11
Patient: 83 year old female
Adverse reactions / side effects: Vomiting, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion, Cognitive Disorder, Blood Sodium Decreased, Delirium
Adverse event resulted in: life threatening event
Suspect drug(s):
Acecomb
Acemin
Citalopram Hydrobromide
Furospirobene
Tegretol
Voltaren
Adverse event in 11 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-07
Patient: 11 year old male, weighing 32.0 kg (70.4 pounds)
Adverse reactions / side effects: Blood PH Increased, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Petechiae, Pyrexia, Erythema, Blood Fibrinogen Decreased, Interstitial Lung Disease, C-Reactive Protein Increased, Acute Respiratory Distress Syndrome, Blood Creatinine Increased, White Blood Cell Count Increased, Cough, Renal Failure Acute, Hypertensive Encephalopathy, Dyspnoea, Blood Urea Increased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Pancytopenia, Life Support, Rash, Protein Total Decreased, Lymphocyte Stimulation Test Positive, Aspartate Aminotransferase Increased, Platelet Count Decreased, PO2 Increased, Lung Infiltration, Calculus Ureteric
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Predonine; Bufferin; Sulpyrine; Kashilon; Cefazolin Sodium; Methylprednisolone 16mg TAB
Adverse event in 11 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-04
Patient: 11 year old male, weighing 32.0 kg (70.4 pounds)
Adverse reactions / side effects: Blood PH Increased, Disseminated Intravascular Coagulation, Petechiae, Blood Albumin Decreased, Blood Fibrinogen Decreased, C-Reactive Protein Increased, Acute Respiratory Distress Syndrome, Blood Creatinine Increased, White Blood Cell Count Increased, Renal Failure Acute, Cough, Dyspnoea, Blood Urea Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Pancytopenia, Protein Total Decreased, Lymphocyte Stimulation Test Positive, Rash, Aspartate Aminotransferase Increased, Platelet Count Decreased, PO2 Increased, Lung Infiltration, Calculus Ureteric
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Predonine; Bufferin; Sulpyrine; Kashilon; Cefazolin Sodium
Page 1 Next >>
|
